StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.20−0.03 (-13.13%)

Close on Nov 16, 2026Market cap $2.73MP/E –Yield –

VolitionRx profit margin

Profit margin (net margin) is net income as a percentage of revenue.

VolitionRx's profit margin for the twelve months ending Jun 30, 2026 was -1043.1%. For fiscal 2025 it was -1352.2%, against -2186.3% the year before. The highest annual figure on record is -1352.2% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1352.2%+834.1
FY2024Dec 31, 2024-2186.3%+2415.4
FY2023Dec 31, 2023-4601.7%+5385.0
FY2022Dec 31, 2022-9986.7%+19990.3
FY2021Dec 31, 2021-29977.0%+121882.6
FY2020Dec 31, 2020-151859.6%−57691.0
FY2019Dec 31, 2019-94168.5%−38615.4
FY2014Dec 31, 2014-55553.1%−48125.1
FY2012Dec 31, 2012-7428.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1837.7%−292.5
Q1 FY2026Mar 31, 2026-676.6%+1524.8
Q4 FY2025Dec 31, 2025-1402.8%+1620.0
Q3 FY2025Sep 30, 2025-857.4%+369.4
Q2 FY2025Jun 30, 2025-1545.2%+219.7
Q1 FY2025Mar 31, 2025-2201.3%+2676.6
Q4 FY2024Dec 31, 2024-3022.8%+584.1
Q3 FY2024Sep 30, 2024-1226.8%+3889.8
Q2 FY2024Jun 30, 2024-1764.9%+2650.6
Q1 FY2024Mar 31, 2024-4877.9%+1044.9
Q4 FY2023Dec 31, 2023-3606.8%+2521.2
Q3 FY2023Sep 30, 2023-5116.6%+18763.9
Q2 FY2023Jun 30, 2023-4415.6%+15035.1
Q1 FY2023Mar 31, 2023-5922.9%+834.8
Q4 FY2022Dec 31, 2022-6128.0%+50811.7
Q3 FY2022Sep 30, 2022-23880.5%+4301.0
Q2 FY2022Jun 30, 2022-19450.6%+3043.5
Q1 FY2022Mar 31, 2022-6757.7%+17235.9
Q4 FY2021Dec 31, 2021-56939.8%+15545.0
Q3 FY2021Sep 30, 2021-28181.5%+725896.4
Q2 FY2021Jun 30, 2021-22494.1%+74600.5
Q1 FY2021Mar 31, 2021-23993.6%+1053090.8
Q4 FY2020Dec 31, 2020-72484.7%−48029.9
Q3 FY2020Sep 30, 2020-754077.9%–
Q2 FY2020Jun 30, 2020-97094.6%–
Q1 FY2020Mar 31, 2020-1077084.4%–
Q3 FY2019Sep 30, 2019-24454.9%–

More VolitionRx figures

See a number that looks wrong?